Ampyra’s Agressive Free Trial Promotion to Patients
Brand: Ampyra (dalfampridine), Tablets
Parent Company: Acorda Therapeutics
Drug Type: Prescription
Drug Category: Neurology
Campaign: Post-Launch
Targeting: Patients, Caregivers
Patient Website: https://ampyra.com/
HCP Website: https://ampyra-hcp.com/